An emergency intubation can create a moment of relief. The breathing tube is in place, its position is confirmed, and the ventilator is supporting a patient who may have been deteriorating only minutes earlier. But the procedure has not answered another urgent question: What happens when the drug that made the patient unconscious wears off, especially if the drug preventing movement is still working?
In anesthesiology, paralysis, sedation, and pain relief have different purposes. A neuromuscular blocker prevents movement; it does not remove pain or guarantee unconsciousness. An induction drug may act for a shorter period than a long-acting paralytic. That mismatch creates the possibility of awareness while a patient cannot move or signal distress. It does not mean every still patient is awake. It means immobility cannot be used as reassurance.
The danger is easy to understand, but harder to see in a busy emergency department. Immediately after intubation, attention may turn to blood pressure, oxygenation, imaging, laboratory results, and transfer. These needs can be urgent and competing. Yet successful ventilation tells us nothing reliable about the patient’s experience. A stable oxygen reading is not a measure of comfort. Neither is the absence of movement.
There is direct evidence that awareness during paralysis occurs. In a prospective multicenter analysis published in Critical Care Medicine in 2022, 13 of 388 selected mechanically ventilated emergency department patients were judged to have experienced awareness with paralysis. The researchers also recorded greater perceived threat in affected patients. The cohort was selected and the number of events small; 3.4 percent is not a universal rate for all emergency intubations. Still, the study challenges the assumption that this is only a theoretical hazard.
Real physician voices, twice a week
Free, and one click to unsubscribe.
A different study asked a different question. In a single-center retrospective review published in 2025, researchers examined 370 adults who received rocuronium for rapid sequence intubation. The proportion who received a sedative agent within 15 minutes of induction was 39 percent in the emergency department and 40 percent in intensive care. That is a medication-timing measure. It cannot tell us how many patients remained conscious, which individual treatment choices were appropriate, or why treatment was delayed. But it identifies a process worth examining.
I would frame the responsibility after emergency intubation as continuing care, rather than an extra task to remember once the airway is secure. When circumstances allow, the team should anticipate the next phase before administering the intubation drugs: which medications may still be active, how comfort and sedation will be maintained, how circulation may constrain treatment, and who will reassess the patient. When intubation must proceed immediately, that plan still needs attention as soon as the most urgent threats are addressed.
This is not a call for deeper sedation in every patient. A critically ill person with severe hypotension may tolerate some drugs poorly. A patient with acute brain injury may require careful neurological evaluation. Others need deeper sedation for specific clinical reasons, while many patients without ongoing paralysis benefit from lighter sedation when feasible. Pain and awareness require attention in all these situations, but the appropriate approach varies.
The Society of Critical Care Medicine’s 2018 guidance supports routine pain assessment, pain treatment before considering additional sedation, and generally lighter sedation for mechanically ventilated adults where appropriate. Its 2025 focused update adds a conditional preference for dexmedetomidine over propofol in ICU patients when light sedation or delirium reduction is a particular priority. These are ICU recommendations, not a universal emergency department drug protocol. They reinforce a larger point: The desired level of sedation must be chosen for the patient, rather than assumed from the presence of a breathing tube.
Pain relief deserves its own place in this plan. A patient may require analgesia even when sedation appears adequate, and a sedative does not necessarily treat pain. Conversely, increasing medication simply because an intubated patient cannot communicate is not a safe substitute for assessment. Decisions need to reflect likely sources of pain, the need for procedures, the patient’s physiology, and what can meaningfully be observed.
Monitoring also has limits. Someone able to communicate can report pain or discomfort. When communication is impossible but movement remains observable, structured behavioral tools may help. During neuromuscular blockade, those behavioral signs may disappear. Routine sedation and pain scales cannot then be interpreted in the usual way. Clinicians must rely on the medication record, expected drug duration, the wider clinical picture, and reassessment appropriate to the circumstances. No monitor can make uncertainty vanish.
The transfer of responsibility is another vulnerable moment. The clinician who performed the intubation often knows what was administered, when, and with what intention. A receiving team may see a patient who appears settled and ventilates adequately, without knowing whether paralysis continues or whether analgesia and sedation have been arranged. A useful handover should make the next decision explicit: what has been given, what is expected to wear off, what remains to be done, and who is responsible for reviewing the plan. This is a proposed practice principle, not a handover tool proven to prevent awareness.
A 2026 systematic review examined 22 studies of interventions intended to improve emergency department post-intubation sedation and analgesia. Half were conference abstracts; methods and outcome definitions varied too much for a meaningful meta-analysis. Some interventions improved process measures, but we do not yet know which approach reliably improves patients’ experience or prevents awareness. Better studies are needed. The absence of a proven single checklist, however, does not erase the underlying responsibility.
The tube may be the most visible sign that an emergency airway procedure succeeded. The patient’s comfort, awareness, and continuing needs are less visible. Emergency intubation should be judged by both what the team accomplished in that moment and whether someone took responsibility for the minutes that followed.
Girishkumar Modi is a senior specialist anesthesiologist at Sheikh Tahnoon Bin Mohammed Medical City and Tawam Hospital (SEHA) in the United Arab Emirates. His clinical practice includes regional anesthesia, trauma and orthopedic anesthesia, neuroanesthesia and spine anesthesia, obstetric anesthesia, pediatric anesthesia, perioperative medicine, and the management of complex surgical patients. He serves as faculty in an anesthesiology residency program accredited by the Accreditation Council for Graduate Medical Education International, where he contributes to resident teaching, clinical supervision, assessment, and mentorship. He also contributes to trauma-service development and multidisciplinary perioperative care.
His academic interests include perioperative physiology and pharmacology, regional anesthesia, total intravenous anesthesia, acute pain management, point-of-care coagulation and hemostasis, medical education, health care economics, and perioperative patient safety. He is active in clinical research, medical writing, and peer review, with publications spanning anesthesiology, pharmacology, perioperative medicine, regional anesthesia, point-of-care coagulation and rotational thromboelastometry, and medical education. His work has appeared in the Mathews Journal of Anesthesia, the Journal of Anesthesia & Pain Medicine, and Anaesthesia, with abstracts presented at the Association of Anaesthetists Winter Scientific Meeting in London and the Integrated Anesthesia and Comprehensive Care Conference in Abu Dhabi.
He also writes commentary on clinical judgment, artificial intelligence, and patient readiness for surgery, including rapid responses in The BMJ such as “Medicine is not a 64-square board: Human oversight requires independent judgment” and “AI systems need a tested exit plan.”
